|
1
|
Akimoto N, Ugai T, Zhong R, Hamada T,
Fujiyoshi K, Giannakis M, Wu K, Cao Y, Ng K and Ogino S: Rising
incidence of early-onset colorectal cancer-a call to action. Nat
Rev Clin Oncol. 18:230–243. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Murphy CC and Zaki TA: Changing
epidemiology of colorectal cancer-birth cohort effects and emerging
risk factors. Nat Rev Gastroenterol Hepatol. 21:25–34.
2024.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chung RY, Tsoi KKF, Kyaw MH, Lui AR, Lai
FTT and Sung JJ: A population-based age-period-cohort study of
colorectal cancer incidence comparing Asia against the West. Cancer
Epidemiol. 59:29–36. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Low EE, Demb J, Liu L, Earles A,
Bustamante R, Williams CD, Provenzale D, Kaltenbach T, Gawron AJ,
Martinez ME and Gupta S: Risk factors for early-onset colorectal
cancer. Gastroenterology. 159:492–501.e7. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gonzalez H, Hagerling C and Werb Z: Roles
of the immune system in cancer: From tumor initiation to metastatic
progression. Genes Dev. 32:1267–1284. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lian J, Yue Y, Yu W and Zhang Y:
Immunosenescence: A key player in cancer development. J Hematol
Oncol. 13(151)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Grasso CS, Giannakis M, Wells DK, Hamada
T, Mu XJ, Quist M, Nowak JA, Nishihara R, Qian ZR, Inamura K, et
al: Genetic mechanisms of immune evasion in colorectal cancer.
Cancer Discov. 8:730–749. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Liu Z, Liang Q, Ren Y, Guo C, Ge X, Wang
L, Cheng Q, Luo P, Zhang Y and Han X: Immunosenescence: Molecular
mechanisms and diseases. Signal Transduct Target Ther.
8(200)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Trzonkowski P, Myśliwska J, Szmit E, Zak
M, Foerster J and Myśliwski A: Lower percentage of
CD8(high+)CD152(+) but not CD8(high+)CD28(+) T lymphocytes in the
elderly may be reverted by interleukin 2 in vitro. Mech Ageing Dev.
123:1283–1293. 2002.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ai L, Xu A and Xu J: Roles of PD-1/PD-L1
pathway: signaling, cancer, and beyond. Adv Exp Med Biol.
1248:33–59. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhu C, Dai Y, Zhang H, Ruan Y, Zhou Y, Dai
Y, Fan L, Jia T, Lu H and Chen Q: T cell exhaustion is associated
with the risk of papillary thyroid carcinoma and can be a
predictive and sensitive biomarker for diagnosis. Diagn Pathol.
16(84)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chen ACY, Jaiswal S, Martinez D, Yerinde
C, Ji K, Miranda V, Fung ME, Weiss SA, Zschummel M, Taguchi K, et
al: The aged tumor microenvironment limits T cell control of
cancer. Nat Immunol. 25:1033–1045. 2024.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li YR and Zúñiga-Pflücker JC: . Thymus
aging and immune reconstitution: Progresses and challenges. Semin
Immunol. 70(101837)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yin C, Pei XY, Shen H, Gao YN, Sun XY,
Wang W, Ge Q and Zhang Y: Thymic homing of activated
CD4+ T cells induces degeneration of the thymic
epithelium through excessive RANK signaling. Sci Rep.
7(2421)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Meng Y, Li Y, Gu H, Chen Z, Cui X and Wang
X: Androgen receptors in corticotropin-releasing hormone neurons
mediate the sexual dimorphism in restraint-induced thymic atrophy.
Proc Natl Acad Sci USA. 122(e2426107122)2025.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Faget DV, Ren Q and Stewart SA: Unmasking
senescence: Context-dependent effects of SASP in cancer. Nat Rev
Cancer. 19:439–453. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Park MD, Le Berichel J, Hamon P, Wilk CM,
Belabed M, Yatim N, Saffon A, Boumelha J, Falcomatà C, Tepper A, et
al: Hematopoietic aging promotes cancer by fueling IL-1α-driven
emergency myelopoiesis. Science. 386(eadn0327)2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ma F, Liu X, Zhang Y, Tao Y, Zhao L,
Abusalamah H, Huffman C, Harbison RA, Puram SV, Wang Y and Peng G:
Tumor extracellular vesicle-derived PD-L1 promotes T cell
senescence through lipid metabolism reprogramming. Sci Transl Med.
17(eadm7269)2025.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Liu X, Meng P, Liu Z, Tian X, Xi J, Du M,
Yang H and Long Q: New insights on targeting extracellular vesicle
release by GW4869 to modulate lipopolysaccharide-induced
neuroinflammation in mice model. Nanomedicine (Lond). 19:2619–2632.
2024.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yu W, Lei Q, Yang L, Qin G, Liu S, Wang D,
Ping Y and Zhang Y: Contradictory roles of lipid metabolism in
immune response within the tumor microenvironment. J Hematol Oncol.
14(187)2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang M, Cui J, Chen H, Cheng Y, Chen Q,
Zong F, Lu X, Qin L, Han Y, Kuai X, et al: Increased SOAT2
expression in aged regulatory T cells is associated with altered
cholesterol metabolism and reduced anti-tumor immunity. Nat Commun.
16(630)2025.PubMed/NCBI View Article : Google Scholar
|
|
22
|
He J, Chai X, Zhang Q, Wang Y, Wang Y,
Yang X, Wu J, Feng B, Sun J, Rui W, et al: The lactate receptor
HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in
colorectal cancer. Nat Immunol. 26:391–403. 2025.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q,
Huang H, Lu H, Song H, Yang B, et al: AARS1 and AARS2 sense
L-lactate to regulate cGAS as global lysine lactyltransferases.
Nature. 634:1229–1237. 2024.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen D, Liu P, Lu X, Li J, Qi D, Zang L,
Lin J, Liu Y, Zhai S, Fu D, et al: Pan-cancer analysis implicates
novel insights of lactate metabolism into immunotherapy response
prediction and survival prognostication. J Exp Clin Cancer Res.
43(125)2024.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Binnewies M, Roberts EW, Kersten K, Chan
V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI,
Ostrand-Rosenberg S, Hedrick CC, et al: Understanding the tumor
immune microenvironment (TIME) for effective therapy. Nat Med.
24:541–550. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhou Z, Wang J, Wang J, Yang S, Wang R,
Zhang G, Li Z, Shi R, Wang Z and Lu Q: Deciphering the tumor immune
microenvironment from a multidimensional omics perspective: Insight
into next-generation CAR-T cell immunotherapy and beyond. Mol
Cancer. 23(131)2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li C, Jiang P, Wei S, Xu X and Wang J:
Regulatory T cells in tumor microenvironment: New mechanisms,
potential therapeutic strategies and future prospects. Mol Cancer.
19(116)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mirlekar B: Tumor promoting roles of
IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer
immunotherapy. SAGE Open Med. 10(20503121211069012)2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nishikawa H and Koyama S: Mechanisms of
regulatory T cell infiltration in tumors: Implications for
innovative immune precision therapies. J Immunother Cancer.
9(e002591)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tan SN, Hao J, Ge J, Yang Y, Liu L, Huang
J, Lin M, Zhao X, Wang G, Yang Z, et al: Regulatory T cells
converted from Th1 cells in tumors suppress cancer immunity via
CD39. J Exp Med. 222(e20240445)2025.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Joshi S and Sharabi A: Targeting
myeloid-derived suppressor cells to enhance natural killer
cell-based immunotherapy. Pharmacol Ther.
235(108114)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
He X, Zhong L, Wang N, Zhao B, Wang Y, Wu
X, Zheng C, Ruan Y, Hou J, Luo Y, et al: Gastric cancer actively
remodels mechanical microenvironment to promote chemotherapy
resistance via MSCs-mediated mitochondrial transfer. Adv Sci
(Weinh). 11(e2404994)2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhou Y, Ren D, Bi H, Yi B, Zhang C, Wang H
and Sun J: Tumor-associated macrophage: Emerging targets for
modulating the tumor microenvironment. Zhongguo Fei Ai Za Zhi.
27:231–240. 2024.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
34
|
He M, Liu Y, Chen S, Deng H, Feng C, Qiao
S, Chen Q, Hu Y, Chen H, Wang X, et al: Serum amyloid A promotes
glycolysis of neutrophils during PD-1 blockade resistance in
hepatocellular carcinoma. Nat Commun. 15(1754)2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Karakasheva TA, Lin EW, Tang Q, Qiao E,
Waldron TJ, Soni M, Klein-Szanto AJ, Sahu V, Basu D, Ohashi S, et
al: IL-6 mediates cross-talk between tumor cells and activated
fibroblasts in the tumor microenvironment. Cancer Res.
78:4957–4970. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Bigos KJ, Quiles CG, Lunj S, Smith DJ,
Krause M, Troost EG, West CM, Hoskin P and Choudhury A: Tumour
response to hypoxia: Understanding the hypoxic tumour
microenvironment to improve treatment outcome in solid tumours.
Front Oncol. 14(1331355)2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Zhang S, Zhao J, Xie F, He H, Johnston LJ,
Dai X, Wu C and Ma X: Dietary fiber-derived short-chain fatty
acids: A potential therapeutic target to alleviate obesity-related
nonalcoholic fatty liver disease. Obes Rev.
22(e13316)2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
De Vos WM, Tilg H, Van Hul M and Cani PD:
Gut microbiome and health: Mechanistic insights. Gut. 71:1020–1032.
2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yu T, Guo F, Yu Y, Sun T, Ma D, Han J,
Qian Y, Kryczek I, Sun D, Nagarsheth N, et al: Fusobacterium
nucleatum promotes chemoresistance to colorectal cancer by
modulating autophagy. Cell. 170:548–563.e16. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wang T, Jin J, Qian C, Lou J, Lin J, Xu A,
Xia K, Jin L, Liu B, Tao H, et al: Estrogen/ER in anti-tumor
immunity regulation to tumor cell and tumor microenvironment.
Cancer Cell Int. 21(295)2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yi J, Wang L, Hu GS, Zhang YY, Du J, Ding
JC, Ji X, Shen HF, Huang HH, Ye F and Liu W: CircPVT1 promotes
ER-positive breast tumorigenesis and drug resistance by targeting
ESR1 and MAVS. EMBO J. 42(e112408)2023.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Hopkins BD, Goncalves MD and Cantley LC:
Insulin-PI3K signalling: An evolutionarily insulated metabolic
driver of cancer. Nat Rev Endocrinol. 16:276–283. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Bader JE, Wolf MM, Lupica-Tondo GL, Madden
MZ, Reinfeld BI, Arner EN, Hathaway ES, Steiner KK, Needle GA,
Hatem Z, et al: Obesity induces PD-1 on macrophages to suppress
anti-tumour immunity. Nature. 630:968–975. 2024.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Francisco V, Pino J, Campos-Cabaleiro V,
Ruiz-Fernández C, Mera A, Gonzalez-Gay MA, Gómez R and Gualillo O:
Obesity, fat mass and immune system: Role for leptin. Front
Physiol. 9(640)2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Tutino V, Notarnicola M, Guerra V, Lorusso
D and Caruso MG: Increased soluble leptin receptor levels are
associated with advanced tumor stage in colorectal cancer patients.
Anticancer Res. 31:3381–3383. 2011.PubMed/NCBI
|
|
46
|
Ma Y, Shen S, Yan Y, Zhang S, Liu S, Tang
Z, Yu J, Ma M, Niu Z, Li Z, et al: Adipocyte thyroid hormone β
receptor-mediated hormone action fine-tunes intracellular glucose
and lipid metabolism and systemic homeostasis. Diabetes.
72:562–574. 2023.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ni W, Mo H, Liu Y, Xu Y, Qin C, Zhou Y, Li
Y, Li Y, Zhou A, Yao S, et al: Targeting cholesterol biosynthesis
promotes anti-tumor immunity by inhibiting long noncoding RNA
SNHG29-mediated YAP activation. Mol Ther. 29:2995–3010.
2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Cho MH, Yoo TG, Jeong SM and Shin DW:
Association of aspirin, metformin, and statin use with gastric
cancer incidence and mortality: A nationwide cohort study. Cancer
Prev Res (Phila). 14:95–104. 2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Gui L, Chen K, Yan J, Chen P, Gao WQ and
Ma B: Targeting the mevalonate pathway potentiates NUAK1
inhibition-induced immunogenic cell death and antitumor immunity.
Cell Rep Med. 6(101913)2025.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Zhao ZF, Li JX, Ye R, Wu X, Gao LL and Niu
BL: Interleukin-6 as a potential molecular target in esophageal
squamous cell carcinoma. Oncol Lett. 11:925–932. 2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ambrosini M, Rousseau B, Manca P, Artz O,
Marabelle A, André T, Maddalena G, Mazzoli G, Intini R, Cohen R, et
al: Immune checkpoint inhibitors for POLE or POLD1
proofreading-deficient metastatic colorectal cancer. Ann Oncol.
35:643–655. 2024.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Le DT, Uram JN, Wang H, Bartlett BR,
Kemberling H, Eyring AD, Skora AD, Luber BS, Azad NS, Laheru D, et
al: PD-1 blockade in tumors with mismatch-repair deficiency. N Engl
J Med. 372:2509–2520. 2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Nunes L, Li F, Wu M, Luo T, Hammarström K,
Torell E, Ljuslinder I, Mezheyeuski A, Edqvist PH, Löfgren-Burström
A, et al: Prognostic genome and transcriptome signatures in
colorectal cancers. Nature. 633:137–146. 2024.PubMed/NCBI View Article : Google Scholar
|
